Squarepoint Ops LLC

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 1642575 NEW YORK, NY

Position in ENTA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$171,351

-$868,932 QoQ

Shares Held

13,567

-79.4% QoQ

Ownership

0.047%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Mar 31, 2026

Squarepoint Ops LLC holds $1,099,779,999 across 233 Biotechnology names. ENTA ranks #196 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	426,723	$141,189,839
2	REGN	Regeneron Pharmaceuticals, Inc.	162,814	$125,796,608
3	RPRX	Royalty Pharma plc	1,349,516	$64,736,282
4	IONS	Ionis Pharmaceuticals Inc	695,276	$52,208,274
5	BBIO	BridgeBio Pharma, Inc.	556,324	$41,312,620
6	MDGL	Madrigal Pharmaceuticals, Inc.	52,884	$27,683,187
7	ARQT	Arcutis Biotherapeutics, Inc.	1,103,490	$25,998,224
8	FOLD	AMICUS THERAPEUTICS, INC.	1,705,829	$24,666,287

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$171,351	13,567	-79.4%	Shares	Defined	2026-05-15
2025-12-31	$1,040,283	65,966	+470.7%	Shares	Defined	2026-02-13
2024-12-31	$66,458	11,558	-89.1%	Shares	Defined	2025-02-14
2023-12-31	$1,001,252	106,403	+287.2%	Shares	Defined	2024-02-14
2023-09-30	$306,962	27,481	+188.3%	Shares	Defined	2023-11-14
2023-03-31	$385,514	9,533	-31.0%	Shares	Defined	2023-05-15
2022-12-31	$642,813	13,818	+165.1%	Shares	Defined	2023-02-14
2022-09-30	$270,398	5,213	+5.9%	Shares	Defined	2022-11-14
2021-06-30	$216,705	4,924	-6.6%	Shares	Defined	2021-08-16
2020-09-30	$241,306	5,271	-19.4%	Shares	Defined	2020-11-16
2020-06-30	$328,222	6,537	-69.8%	Shares	Defined	2020-08-14
2020-03-31	$1,111,453	21,611	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.